N-(4-Bromo-2-methylphenyl)-2-chloroacetamide

Catalog No. :
ACXEBQ761
CAS No. :
96686-51-0
Molecular Formula :
C9H9BrClNO
Molecular Weight :
262.53

IUPAC Name:N-(4-bromo-2-methylphenyl)-2-chloroacetamide

N-(4-Bromo-2-methylphenyl)-2-chloroacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$207.00Login to see priceIn stockIn stock
1g97%$574.00Login to see priceIn stockIn stock
5g97%$2225.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-Bromo-2-methylphenyl)-2-chloroacetamide
IUPAC NameN-(4-bromo-2-methylphenyl)-2-chloroacetamide
MDL No.MFCD00157388
Molecular FormulaC9H9BrClNO
Molecular Weight262.53
SMILESO=C(NC1=CC=C(Br)C=C1C)CCl
InChI KeyAKNLFHJQVCPHHO-UHFFFAOYSA-N
SynonymCosan 528;Cosan 528, 96686-51-0;Acetamide,N-(4-bromo-2-methylphenyl)-2-chloro-;COSAN-528; COSAN 528; COSAN528;chloro-acetic acid-(4-bromo-2-methyl-anilide);2-Chloro-N-(2-methyl-4-bromophenyl)acetamide;Cosan 528, 10 mM in DMSO;4'-BROMO-2-CHLORO-O-ACETOTOLUIDIDE
CAS No.96686-51-0
PubChem CID2097895

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H317-H319
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACXEBQ761 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACATZC048 route compound structure diagram
    ACATZC048583-75-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXEBQ761 route product structure diagram
    ACXEBQ76196686-51-0 In Stock
Inquiry

2. ACXEBQ761 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACATZC048 route compound structure diagram
    ACATZC048583-75-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXEBQ761 route product structure diagram
    ACXEBQ76196686-51-0 In Stock
Inquiry

Comments (0)